111 (YI) EPS (Basic) (2017 - 2025)

111 (YI) posted EPS (Basic) of -$0.01 for Q4 2025, down 27.54% sequentially from -$0.01 in Q3 2025, and up 15.72% YoY from -$0.01 in Q4 2024.

111 (YI) EPS (Basic) (2017 - 2025) Analysis & Trends

111 has reported EPS (Basic) for 9 years, with the latest figure at -$0.01 in Q4 2025.

Quarterly EPS (Basic) rose 15.72% year-over-year to -$0.01 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$0.05 (down 2.12% YoY) and the FY2025 annual result came in at -$0.05, down 5.69% from the prior year.
EPS (Basic) eased to -$0.01 in Q4 2025 per YI's latest filing, from -$0.01 in the prior quarter.
Over five years, EPS (Basic) peaked at -$0.01 in Q3 2025 and troughed at -$0.24 in Q3 2021.
A 5-year average of -$0.07 and a median of -$0.06 in 2023 frame the typical range for EPS (Basic).
The sharpest annual moves came in 2021 and 2024: EPS (Basic) sank 142.84% in 2021, then soared 91.0% in 2024.
Over 5 years, EPS (Basic) stood at -$0.11 in 2021, then advanced by 5.49% to -$0.1 in 2022, then slumped by 76.5% to -$0.18 in 2023, then jumped by 91.0% to -$0.02 in 2024, then increased by 15.72% to -$0.01 in 2025.
According to Business Quant data, EPS (Basic) over the past three periods registered -$0.01, -$0.01, and -$0.02 for Q4 2025, Q3 2025, and Q2 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EPS (Basic) (Qtr)
1	Mckesson	102.29 Bn	97.12 Bn	3.69 Bn	8.69
2	Cencora	61.58 Bn	58.77 Bn	3.61 Bn	4.02
3	Cardinal Health	53.91 Bn	49.06 Bn	2.56 Bn	1.69
4	Henry Schein	10.05 Bn	9.90 Bn	1.10 Bn	0.91
5	Akso Health	715.48 Mn	715.28 Mn	-	-
6	Edap Tms	156.49 Mn	134.95 Mn	7.34 Mn	-0.39
7	Accendra Health	96.25 Mn	88.60 Mn	263.41 Mn	-1.16
8	111	30.87 Mn	109.39 Mn	18.18 Mn	-0.61
9	Cosmos Health	13.08 Mn	10.63 Mn	1.51 Mn	-0.10
10	VitaNova Life Sciences	11.51 Mn	9.91 Mn	264,662.00	0.00

Download Data